Smoking Cessation Aids Market to Grow with a CAGR of 11.40% through 2028
Increase in the awareness of health concern and Rise
in Digital Smoking Cessation Solutions is expected to drive the Global Smoking
Cessation Aids Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Smoking
Cessation Aids Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Smoking Cessation Aids
Market stood at USD 23.02 billion in 2022 and is anticipated to grow with a
CAGR of 11.40% in the forecast period, 2024-2028. The awareness among
individuals regarding Smoking Cessation Aids has led to favorable market
conditions for the global Smoking Cessation Aids market. Several factors
contribute to the growth of various Smoking Cessation Aids products.
The Increased awareness of the severe health risks
associated with smoking is a significant driver. The public is now more
informed about the link between smoking and conditions like lung cancer, heart
disease, and respiratory problems. This awareness motivates individuals to quit
smoking and seek assistance, boosting the demand for cessation aids. People are
increasingly concerned about their own well-being and longevity. Smoking
cessation is seen as a crucial step towards a healthier life. Individuals are
willing to invest in cessation aids as they prioritize their health and aim for
a smoke-free future.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Smoking Cessation Aids Market”
The Global Smoking Cessation Aids Market is witnessing
trends such as the rise of digital solutions, the evolution of nicotine
replacement therapies, and a greater emphasis on behavioral support and
counseling. These trends reflect the market's adaptability and commitment to
providing effective and diverse options for individuals seeking to quit smoking
and improve their health, which will further fuel market growth.
In June 2023, Roche announced that it has submitted a
regulatory submission to the European Medicines Agency (EMA) for ocrelizumab
for the treatment of primary progressive multiple sclerosis (PPMS). Ocrelizumab
is a monoclonal antibody that is designed to target B cells, which are a type
of white blood cell that plays a role in the immune system.
NRT offers a wide range of delivery methods, including
nicotine patches, gum, lozenges, nasal sprays, inhalers, and oral tablets. This
variety caters to individual preferences and needs. Smokers can choose the NRT
product that aligns with their comfort level and lifestyle, enhancing the
chances of successful smoking cessation.
In a world where time is of the essence, good health
is crucial for keeping up with the demands of a fast-paced lifestyle. Smoking
cessation directly contributes to improved health by reducing the risk of
smoking-related diseases such as lung cancer, heart disease, and respiratory
issues. This means fewer sick days, better overall well-being, and increased
energy levels to meet daily challenges. Smoking can negatively impact cognitive
function and concentration due to the addiction-related distractions of nicotine
cravings. By quitting smoking, individuals can experience improved focus,
mental clarity, and productivity. In a fast-paced world where multitasking and
quick decision-making are essential, this cognitive enhancement is highly
advantageous. Smoking cessation leads to improved lung function and
cardiovascular health. Smokers who quit often notice enhanced endurance, better
physical fitness, and increased stamina. This improved physical condition helps
individuals keep up with the demands of a busy lifestyle, whether it involves
work, travel, or recreational activities. Smoking is an expensive habit, and
quitting can result in substantial financial savings. In a fast-paced world
where financial stability is crucial, the money saved from not purchasing
cigarettes can be allocated towards other essential expenses or investments,
reducing financial stress..
The growing awareness among consumers regarding health
and wellness has shifted the focus towards the ideology of "prevention is
better than cure." As a result, more individuals are relying on
nutraceuticals, functional foods, and dietary and Smoking Cessation Aids to
lead a healthy and disease-free life.
In
recent times, smoking cessation has gained increasing attention and
significance as individuals and public health organizations recognize the
detrimental health effects of smoking. Smoking cessation refers to the process
of quitting smoking and the various methods and strategies employed to achieve
this goal. There has been a significant increase in health awareness and
education regarding the risks associated with smoking. Public health campaigns,
educational programs, and the dissemination of research findings have
highlighted the link between smoking and various health conditions, including
lung cancer, heart disease, respiratory disorders, and more. This heightened
awareness has motivated individuals to seek ways to quit smoking. Governments
worldwide have taken proactive measures to curb smoking. Stringent regulations
on tobacco advertising, graphic warning labels on cigarette packages,
restrictions on smoking in public places, and increased taxes on tobacco
products have been implemented to discourage smoking. These initiatives have
created an environment where quitting smoking is not only desirable but also
supported by public policy. Recent technological advancements have
revolutionized smoking cessation efforts. Mobile applications, online support
communities, and telemedicine services have emerged as convenient and
accessible tools for individuals looking to quit smoking. These digital
solutions offer personalized plans, real-time tracking, and immediate support,
making it easier for smokers to access help when and where they need it..The
Global Smoking Cessation Aids Market is segmented into Product, end-user, regional
distribution, and company.
Based on its product, the NRT offers a wide range of
delivery methods, including nicotine patches, gum, lozenges, nasal sprays,
inhalers, and oral tablets. This variety caters to individual preferences and
needs. Smokers can choose the NRT product that aligns with their comfort level
and lifestyle, enhancing the chances of successful smoking cessation. NRT
products provide a controlled and gradual reduction in nicotine intake, which
is crucial for minimizing withdrawal symptoms and cravings. Smokers can wean
themselves off nicotine gradually, reducing the shock of quitting abruptly.
This approach increases the likelihood of sustained abstinence from smoking.
NRT is available in both prescription and over the counter (OTC) forms, making
it accessible to a broad range of smoke over the counteructs, such as nicotine
gum and patches, are readily available in pharmacies and stores without a
doctor's prescription. This accessibility encourages more individuals to try
NRT as a smoking cessation aid. NRT has a track record of effectiveness in
helping smokers quit. Clinical studies and real-world use have demonstrated its
ability to reduce cravings and withdrawal symptoms, increasing the likelihood
of successful smoking cessation. This established efficacy contributes to its
dominance in the market.
Based on region, North America segment is expected to
grow during the forecast period. North America, including the United
States and Mexico, has a significant smoking population. This large base of
smokers creates a substantial market for smoking cessation aids. The desire to
quit smoking and the availability of these aids have contributed to North
America's prominence.
North America has seen a considerable increase in
health awareness and education regarding the risks associated with smoking. As
a result, there is a strong motivation among smokers to quit for health
reasons, driving the demand for cessation aids.
The region boasts an advanced healthcare
infrastructure, including a vast network of retail pharmacies and healthcare
providers. This infrastructure ensures easy access to smoking cessation aids,
professional guidance, and prescription medications.
The Asia-Pacific market is poised to be the
fastest-growing market, has the largest smoking population globally, with
countries like China and India having a significant number of smokers. As
awareness of smoking-related health risks grows, more individuals in the region
are seeking ways to quit. Similar to North America, the APAC region is
experiencing a rising trend in health consciousness. People are becoming more
aware of the health risks of smoking and are actively seeking smoking cessation
solutions. Governments in APAC countries are taking proactive measures to
combat smoking. They are implementing anti-smoking campaigns, imposing higher
taxes on tobacco products, and introducing regulations to discourage smoking.
These initiatives drive the demand for cessation aids. The growth of the middle
class in many APAC countries has increased disposable incomes. This allows more
individuals to afford smoking cessation aids, contributing to market growth.
Major companies operating in
Global Smoking Cessation Aids Market are:
- Pfizer Inc.
- GlaxoSmithKline PLC
- Hoffmann-La Roche AG
- Novartis AG
- Johnson and Johnson
- Bayer AG
- Cipla Ltd
- Takeda Pharmaceuticals Co. Ltd
- British American Tobacco PLC
- Kimree Technology Inc
- Imperial Tobacco Ltd
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Technological Advancements in Smoking Cessation
Aids and changing lifestyle stigma are key drivers of the Smoking Cessation
Aids and supplement market. In recent years, The global trend towards
health-conscious living is driving individuals to make healthier choices.
Quitting smoking aligns with this lifestyle shift, and cessation aids support
this transition, making it more likely for people to quit successfully.
Moreover, the growing consumer emphasis on preventative healthcare products has
enhanced production and marketing efforts. To meet the demands of the market,
manufacturers are increasingly incorporating cutting-edge technologies with
high production efficiency. Rising consumer acceptance and continuous product
innovation will further ensure the growth of the Smoking Cessation Aidss and
supplements market in the coming years.,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“Smoking Cessation Aids Market –
Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028
Segmented By Product (Nicotine Replacement Therapy,
Drugs, electronic Cigarette Smoking Cessation Aids Market – Global Industry
Size, Share, Trends, Opportunity, & Forecast 2018-2028 Segmented By Product
(Nicotine Replacement Therapy, Drugs, electronic Cigarettes, Others), By
End-User (Hospital Pharmacies, Online Channels, Retail Pharmacies, Other), By
Region, Competitions, Others), By End-User (Hospital Pharmacies, Online
Channels, Retail Pharmacies, Other), By Region, Competition”, has evaluated the future growth potential of Global
Smoking Cessation Aids Market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Smoking
Cessation Aids Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com